Nemaura Medical

[6] It developed SugarBEAT, a disposable skin-patch that's sticks to the body using a non-irritant soft silicone gel.

The skin-patch connects to a rechargeable transmitter which detects blood sugar and transfers the data to a mobile app at a 5-minute interval.

Electronic currents are used to draw interstitial fluid to the surface which analyses the glucose level.

[7][1][14] The first model of SugarBEAT is wired to a smartwatch and received CE approval in February, 2016.

[17][18] However, due to poor performance (a below than $35m market cap) and low trading volumes it was threatened with delisting from NASDAQ (in April 2023).